140 related articles for article (PubMed ID: 19377512)
1. Reversibility and recurrence of IGF-IR-induced mammary tumors.
Jones RA; Campbell CI; Wood GA; Petrik JJ; Moorehead RA
Oncogene; 2009 May; 28(21):2152-62. PubMed ID: 19377512
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
3. Preneoplastic changes persist after IGF-IR downregulation and tumor regression.
Jones RA; Petrik JJ; Moorehead RA
Oncogene; 2010 Aug; 29(34):4779-86. PubMed ID: 20543862
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
Jones RA; Campbell CI; Petrik JJ; Moorehead RA
Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
[TBL] [Abstract][Full Text] [Related]
5. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
Surmacz E; Bartucci M
J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
[TBL] [Abstract][Full Text] [Related]
6. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
Sutherland BW; Knoblaugh SE; Kaplan-Lefko PJ; Wang F; Holzenberger M; Greenberg NM
Cancer Res; 2008 May; 68(9):3495-504. PubMed ID: 18451178
[TBL] [Abstract][Full Text] [Related]
7. Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation.
Jones RA; Campbell CI; Gunther EJ; Chodosh LA; Petrik JJ; Khokha R; Moorehead RA
Oncogene; 2007 Mar; 26(11):1636-44. PubMed ID: 16953219
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice.
Dong AQ; Kong MJ; Ma ZY; Qian JF; Xu XH
Cell Biol Int; 2007 May; 31(5):500-7. PubMed ID: 17196841
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
10. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer.
Sarfstein R; Maor S; Reizner N; Abramovitch S; Werner H
Mol Cell Endocrinol; 2006 Jun; 252(1-2):241-6. PubMed ID: 16647191
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.
Turner BC; Haffty BG; Narayanan L; Yuan J; Havre PA; Gumbs AA; Kaplan L; Burgaud JL; Carter D; Baserga R; Glazer PM
Cancer Res; 1997 Aug; 57(15):3079-83. PubMed ID: 9242428
[TBL] [Abstract][Full Text] [Related]
13. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.
Werner H; Maor S
Trends Endocrinol Metab; 2006 Aug; 17(6):236-42. PubMed ID: 16815029
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
Glait C; Tencer L; Ravid D; Sarfstein R; Liscovitch M; Werner H
Exp Cell Res; 2006 Nov; 312(19):3899-908. PubMed ID: 17014845
[TBL] [Abstract][Full Text] [Related]
15. Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations.
Maor S; Yosepovich A; Papa MZ; Yarden RI; Mayer D; Friedman E; Werner H
Cancer Lett; 2007 Nov; 257(2):236-43. PubMed ID: 17766039
[TBL] [Abstract][Full Text] [Related]
16. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.
Tognon CE; Somasiri AM; Evdokimova VE; Trigo G; Uy EE; Melnyk N; Carboni JM; Gottardis MM; Roskelley CD; Pollak M; Sorensen PH
Cancer Res; 2011 Feb; 71(3):1060-70. PubMed ID: 21148487
[TBL] [Abstract][Full Text] [Related]
17. Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor.
Carboni JM; Lee AV; Hadsell DL; Rowley BR; Lee FY; Bol DK; Camuso AE; Gottardis M; Greer AF; Ho CP; Hurlburt W; Li A; Saulnier M; Velaparthi U; Wang C; Wen ML; Westhouse RA; Wittman M; Zimmermann K; Rupnow BA; Wong TW
Cancer Res; 2005 May; 65(9):3781-7. PubMed ID: 15867374
[TBL] [Abstract][Full Text] [Related]
18. Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells.
Modha G; Blanchard A; Sidorchuk J; Venditti M; Shiu R; Myal Y
Endocrine; 2003 Dec; 22(3):293-303. PubMed ID: 14709803
[TBL] [Abstract][Full Text] [Related]
19. The insulin-like growth factor-I receptor as an oncogene.
Werner H; Bruchim I
Arch Physiol Biochem; 2009 May; 115(2):58-71. PubMed ID: 19485702
[TBL] [Abstract][Full Text] [Related]
20. Generation of a conditionally transformed murine embryonic fibroblast cell line using doxycycline-dependent IGF-1R overexpression.
Graeser R; Vrignaud P; Esser N; Umber S; Zirrgiebel U; Chiron M; Schaechtele C; Kubbutat MH
J Biomol Screen; 2012 Mar; 17(3):339-49. PubMed ID: 22002421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
